Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone

Osteoporosis International

Volumn 8, Issue 5, 1998, Pages 428-435

  Balena, R ^a   Kleerekoper, M ^a   Foldes, J A ^a   Shih, M S ^a   Sudhaker Rao, D ^a   Schober, H C ^a   Parfitt, A M ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

Bone histomorphometry; Osteomalacia; Tetracycline labeling; Vitamin D

Indexed keywords

CALCIUM; ERGOCALCIFEROL; FLUORIDE SODIUM; VITAMIN D;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE MINERALIZATION; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOBLAST; OSTEOID; OSTEOMALACIA; OSTEOPOROSIS; PRIORITY JOURNAL; THICKNESS; TIME; TRABECULAR BONE;

AGED; BONE AND BONES; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; SODIUM FLUORIDE; VITAMIN D;

EID: 0031766376     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050087     Document Type: Article

References (44)

1. Riggs BL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802-9.
2. Kleerekoper M, Peterson E, Nelson DA, Phillips E, Schork MA, Tilley BC, et al. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1991;1:155-61.
3. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Ann Intern Med 1995;123:401-8.
4. Meunier PJ, Sebert JL, Reginster JY, Avouac B, Briancon D, Fauquert P, et al., and the FAVOS Study Group. Fluoride salts compared to calcium-vitamin D in the treatment of established postmenopausal osteoporosis: the FAVOS study. Osteoporos Int 1996;6(Suppl 1):S251.
5. Kleerekoper M, Balena R. Fluorides and osteoporosis. Annu Rev Nutr 1991;11:309-24.
6. Cass RM, Croft JD Jr, Perkins P, Nye W, Waterhouse C, Terry R, New bone formation in osteoporosis following treatment with sodium fluoride. Arch Intern Med 1966;118:111-6
7. Kanis JA, Meunier PJ. Should we use fluoride to treat osteoporosis? A review. Q J Med 1984;53:145-64.
8. Fratzl P, Roschger P, Eschberger J, Abendroth B, Klaushofer K. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle X-ray-scattering study. J Bone Miner Res 1994;9:1541-9.
9. Boivin G, Grousson B, Meunier PJ. X-ray microanalysis of fluoride distribution in microfracture calluses in cancellous iliac bone from osteoporotic patients treated with fluoride and untreated. J Bone Miner Res 1991;6:1183-90.
10. Parfitt AM. Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 1992;13:341-7.
11. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972;53:43-9.
12. Kleerekoper M, Frame B, Villanueva AR, Oliver I, Rao DS, Matkovic V, et al. Treatment of osteoporosis with sodium fluoride alternating with calcium and vitamin D. In: DeLuca HF, Frost H, Jee W, Johnston C, Parfitt AM, editors. Osteoporosis: recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981;441-8.
13. Parfitt AM, Podenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 1985;6:211-20.
14. Parfitt AM, Foldes J, Villanueva AR, Shih M-S. The difference in label length between demethylchlortetracycline and oxytetracycline: implications for the interpretation of bone histomorphometry. Calcif Tissue Int 1991;48:74-7.
15. Parfitt AM. Surface specific bone remodeling in health and disease. In: Kleerekoper M, Krane S, editors. Clinical disorders of bone and mineral metabolism. New York: Mary Ann Liebert, 1989:7-14.
16. Foldes J, Shih M-S, Parfitt AM. Frequency distributions of tetracycline based measurements: implications for the interpretation of bone formation indices in the absence of double labelled surfaces. J Bone Miner Res 1990,5:1063-7.
17. Parfitt AM. Osteomalacia and related disorders. In: Avioli LV, Krane SM, editors. Metabolic bone disease and clinically related disorders, 3rd ed. San Diego: Academic Press, 1997:327-86.
18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry nomenclature, symbols and units: report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2:595-610.
19. Hochberg Y, Tamhane AC. Multiple comparison procedures. New York: Wiley. 1987.
20. Sokal RR, Rohlf FJ. Biometry. 2nd ed. San Francisco: WH Freeman. 1981.
21. Neter J, Wasserman W, Kutner M. Applied linear statistical methods. Homewood, Illinois: Richard Erwin, 1985.
22. Altman DG. Practical statistics for medical research. London: Chapman and Hall. 1991.
23. Schenk RK, Merz WA, Reutter FW. Fluoride in osteoporosis: quantitative histological studies on bone structure and bone remodelling in serial biopsies of the iliac crest. In: Vischer T. editor. Fluoride in medicine. Bern, Switzerland: Hans Huber, 1970:153-68.
24. Aaron JE, De Vernejoul M-C, Kanis JA. The effect of sodium fluoride on trabecular architecture. Bone 1991;12:307-10.
25. Schnitzler CM, Wing JR, Raal FJ, ver der Merwe MT, Mesquita JM, Gear KA, et al. Fewer bone histomorphometric abnormalities with intermittent than with continous slow-release sodium fluoride therapy. Osteoporos Int 1997;7:376-89.
26. Quarles LD, Gitelman JJ, Drezner MK. Induction of de novo bone formation in the beale: a novel effect of aluminum. J Clin Invest 1988;81:1056-66.
27. 2 for five years. Bone 1991;12:33-7.
28. Zerwekh JE, Hagler HK, Sakhaee K, Gottschalk F, Peterson RD, Pak CYC. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis. Bone 1994; 15:691-9.
29. Parfitt AM. The physiologic and pathogeneric significance of bone histomorphometric data. In: Coe FL, Favus MJ, editors. Disorders of bone and mineral metabolism. New York: Raven Press. 1992;475-89.
30. Lundy MW, Stauffer M, Wergedal JE, Baylink DJ, Featherstone JDB, Hodgson SF, at al. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int 1995;5:115-29.
31. Sebert JL, Richard P, Mennecier I, Bisset JP, Loeb G. Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study. Osteoporos Int 1995;5:108-14.
32. Bell GH, Dunbar O, Beck JS, Gibb A. Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Res 1967;1:75-86.
33. Olah AJ, Reutter FW, Schenk RK. Histological bone changes after long-term treatment with sodium fluoride. In: Kuhlencordt F, Kruse H-P, editors. Calcium metabolism, bone and metabolic bone diseases. Berlin, Heidelberg, New York: Springer, 1975: 146-50.
34. Kuntz D, Marie P, Naveau B, Maziere B, Tubiana M, Ryckewaert A. Extended treatment of primary osteoporosis by sodium fluoride combined with 25 hydroxy-cholecalciferol. Clin Rheumatol 1984;3:145-53.
35. Boivin G, Dupuis J, Meunier PJ. Fluoride and osteoporosis. In: Simopoulos AP, Galli C, editors. World review of nutrition and dietetics. Basel: S Karger, 1993;80-103.
36. Briancon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 1981;12.629-48.
37. Parfitt AM. Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis, San Diego: Academic Press, 1996;315-29.
38. 2 on trabecular bone balance and remodeling in osteoporotics. Bone 1985;6:381-89.
39. Parfitt AM. Bone-forming cells in clinical conditions. In: Hall BK. editor. Bone: a treatise, vol. 1. The osteoblast and osteocyte. Caldwell, NJ; Telford Press, 1990:351-429.
40. Parfitt AM, Han Z-H, Palnitkar S, Rao DS, Shih M-S, Nelson D Effects of ethnicity and age of menopause on osteoblast function, bone mineralization and osteoid accumulation in iliac bone. J Bone Miner Res 1997:12;1864-73.
41. Dure-Smith BA, Farley SM, Linkhart SG, Farley JR, Baylink DJ. Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation. J Clin Endocrinol Metab 1996; 81: 269-75.
42. Schenk RK, Olah AJ. What is osteomalacia? Adv Exp Biol Med 1980;128:549-62.
43. Cheng P-T, Bader SM, Grynpas MD. Biphasic sodium fluoride effects on bone and bone mineral: a review. Cells Materials 1995;5:271-82.
44. Murray TM, Ste-Marie L-G. Fluoride therapy for osteoporosis. Can Med Assoc J 1996;155:949-54.